The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at over $344,000, is against Roche's existing GSA Schedule #V797P-7347A for Critical Analyzers, Laboratory (FSS-66-III) and provides the DHA with a streamlined vehicle to acquire reagents, kits, and consumables for critical care analyzers on an as-needed basis over a 5-year ordering period. This award does not have a set-aside designation.
The original solicitation indicates the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory required instrumentation, reagents, consumables, and support to perform chemistry, immunology, and molecular assays to provide timely clinical diagnostic testing and patient care. The government determined that Roche Diagnostics was the sole source able to provide the specific reagents and integrated platform meeting the required standards and regulations. Through multiple BPA call orders, Roche has supplied the USAFSAM laboratory with its automated chemistry, immunoassay, and molecular testing platforms, including associated kits, reagents, and assays, to support the Air Force's medical testing and epidemiological surveillance capabilities.